Data / Form D filings / Cell Source, Inc.
Cell Source, Inc.: Form D filings
Cell Source, Inc., a biotechnology company in New York, NY, filed 5 Form D notices with the SEC between 2015 and 2023. The latest, on October 6, 2023, reports $3.9 million sold of an offering with no set size to 48 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 57 WEST 57TH STREET, SUITE 400, New York, NY, 10019
- Phone
- (616) 416-7896
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Nevada
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1569340
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 6, 2023 | New notice | Indefinite | $3,905,134 | 48 | Dec 10, 2020 | sec.gov | |
| Oct 18, 2019 | New notice | $10,000,000 | $8,880,234 | $1,119,766 | 62 | Sep 4, 2016 | sec.gov |
| Nov 13, 2015 | New notice | $3,000,000 | $252,500 | $2,747,500 | 5 | Nov 6, 2015 | sec.gov |
| Jul 28, 2015 | New notice | $1,000,000 | $145,000 | $855,000 | 3 | Jul 24, 2015 | sec.gov |
| Jun 3, 2015 | New notice | $1,000,000 | $750,000 | $250,000 | 3 | Mar 26, 2015 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Dennis Brown | Director | |
| George Verstraete | Director | |
| Darlene Soave | Director | |
| Itamar Shimrat | Executive Officer |
Other biotechnology companies in New York that filed recently
- Swep Bio, Inc. $2.5 million · Oct 29, 2026
- Hypercell Technologies Inc. $3 million · Oct 14, 2026
- CAD Therapeutics, Inc. $4 million · Oct 2, 2026
- Vicora, Inc. $2.3 million · Sep 18, 2026
- GevRx Nutraceuticals, Inc. $300,000 · Sep 18, 2026
- Episteme Prognostics, Inc. $5.1 million · Sep 4, 2026
Every Form D from the week of Oct 2, 2023 · All recent filings in New York · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Cell Source, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.